Stuart Lavin is a Global Clinical Program Excellence Lead at Bayer UK, a position they have held since 2024. Previously, from 2017 to 2019, they served as the Global Clinical Program Excellence Lead at Bayer and have extensive experience in clinical project management, including roles at e-Therapeutics PLC and AstraZeneca. Stuart's career began with a BSc from Aston University, which they completed in 2001, and has included significant positions at GlaxoSmithKline and Quintiles.
This person is not in the org chart
This person is not in any teams
This person is not in any offices